238 related articles for article (PubMed ID: 35282443)
1. Blood Bacterial 16S rRNA Gene Alterations in Women With Polycystic Ovary Syndrome.
Wang Q; Wang Q; Zhao L; Bin Y; Wang L; Wang L; Zhang K; Li Q
Front Endocrinol (Lausanne); 2022; 13():814520. PubMed ID: 35282443
[TBL] [Abstract][Full Text] [Related]
2. Characterization of gut microbiota in polycystic ovary syndrome: Findings from a lean population.
Mammadova G; Ozkul C; Yilmaz Isikhan S; Acikgoz A; Yildiz BO
Eur J Clin Invest; 2021 Apr; 51(4):e13417. PubMed ID: 32991745
[TBL] [Abstract][Full Text] [Related]
3. Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study.
Lindheim L; Bashir M; Münzker J; Trummer C; Zachhuber V; Leber B; Horvath A; Pieber TR; Gorkiewicz G; Stadlbauer V; Obermayer-Pietsch B
PLoS One; 2017; 12(1):e0168390. PubMed ID: 28045919
[TBL] [Abstract][Full Text] [Related]
4. Changes in Vaginal Microbiome Diversity in Women With Polycystic Ovary Syndrome.
Lu C; Wang H; Yang J; Zhang X; Chen Y; Feng R; Qian Y
Front Cell Infect Microbiol; 2021; 11():755741. PubMed ID: 34804995
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbial Diversity in Women With Polycystic Ovary Syndrome Correlates With Hyperandrogenism.
Torres PJ; Siakowska M; Banaszewska B; Pawelczyk L; Duleba AJ; Kelley ST; Thackray VG
J Clin Endocrinol Metab; 2018 Apr; 103(4):1502-1511. PubMed ID: 29370410
[TBL] [Abstract][Full Text] [Related]
6. Alterations of gut microbiota biodiversity and relative abundance in women with PCOS: A systematic review and meta-analysis.
Zou Y; Liao R; Cheng R; Chung H; Zhu H; Huang Y
Microb Pathog; 2023 Nov; 184():106370. PubMed ID: 37739322
[TBL] [Abstract][Full Text] [Related]
7. Gut Microbiota and Oral Contraceptive Use in Overweight and Obese Patients with Polycystic Ovary Syndrome.
Eyupoglu ND; Ergunay K; Acikgoz A; Akyon Y; Yilmaz E; Yildiz BO
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32860695
[TBL] [Abstract][Full Text] [Related]
8. Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome.
Li N; Li Y; Qian C; Liu Q; Cao W; Ma M; He R; Chen R; Geng R; Liu Y
Front Cell Infect Microbiol; 2020; 10():624504. PubMed ID: 33665172
[TBL] [Abstract][Full Text] [Related]
9.
Hassan S; Kaakinen MA; Draisma H; Zudina L; Ganie MA; Rashid A; Balkhiyarova Z; Kiran GS; Vogazianos P; Shammas C; Selvin J; Antoniades A; Demirkan A; Prokopenko I
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205422
[TBL] [Abstract][Full Text] [Related]
10. 16S rDNA Full-Length Assembly Sequencing Technology Analysis of Intestinal Microbiome in Polycystic Ovary Syndrome.
Dong S; Jiao J; Jia S; Li G; Zhang W; Yang K; Wang Z; Liu C; Li D; Wang X
Front Cell Infect Microbiol; 2021; 11():634981. PubMed ID: 34041041
[TBL] [Abstract][Full Text] [Related]
11. Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome.
Jobira B; Frank DN; Silveira LJ; Pyle L; Kelsey MM; Garcia-Reyes Y; Robertson CE; Ir D; Nadeau KJ; Cree-Green M
PLoS One; 2021; 16(1):e0245219. PubMed ID: 33465100
[TBL] [Abstract][Full Text] [Related]
12. Association between polycystic ovary syndrome and the vaginal microbiome: A case-control study.
Hong X; Qin P; Huang K; Ding X; Ma J; Xuan Y; Zhu X; Peng D; Wang B
Clin Endocrinol (Oxf); 2020 Jul; 93(1):52-60. PubMed ID: 32311120
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study.
Zeng B; Lai Z; Sun L; Zhang Z; Yang J; Li Z; Lin J; Zhang Z
Res Microbiol; 2019; 170(1):43-52. PubMed ID: 30292647
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the gut microbiota in polycystic ovary syndrome with dyslipidemia.
Yang T; Li G; Xu Y; He X; Song B; Cao Y
BMC Microbiol; 2024 May; 24(1):169. PubMed ID: 38760705
[TBL] [Abstract][Full Text] [Related]
15. The Gut Microbiome in Polycystic Ovary Syndrome and Its Association with Metabolic Traits.
Lüll K; Arffman RK; Sola-Leyva A; Molina NM; Aasmets O; Herzig KH; Plaza-Díaz J; Franks S; Morin-Papunen L; Tapanainen JS; Salumets A; Altmäe S; Piltonen TT; Org E
J Clin Endocrinol Metab; 2021 Mar; 106(3):858-871. PubMed ID: 33205157
[TBL] [Abstract][Full Text] [Related]
16. Obese Adolescents With PCOS Have Altered Biodiversity and Relative Abundance in Gastrointestinal Microbiota.
Jobira B; Frank DN; Pyle L; Silveira LJ; Kelsey MM; Garcia-Reyes Y; Robertson CE; Ir D; Nadeau KJ; Cree-Green M
J Clin Endocrinol Metab; 2020 Jun; 105(6):e2134-44. PubMed ID: 31970418
[TBL] [Abstract][Full Text] [Related]
17. Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet.
Yang J; Wang E; Jiang M; Tan Y; Yao F; Sun C; Pan L; Gao L; Yao J
J Ovarian Res; 2023 Jun; 16(1):109. PubMed ID: 37277785
[TBL] [Abstract][Full Text] [Related]
18. Berberine Improves the Symptoms of DHEA-Induced PCOS Rats by Regulating Gut Microbiotas and Metabolites.
Shen HR; Xu X; Ye D; Li XL
Gynecol Obstet Invest; 2021; 86(4):388-397. PubMed ID: 34515131
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiome in PCOS associates to serum metabolomics: a cross-sectional study.
Yu Z; Qin E; Cheng S; Yang H; Liu R; Xu T; Liu Y; Yuan J; Yu S; Yang J; Liang F
Sci Rep; 2022 Dec; 12(1):22184. PubMed ID: 36564416
[TBL] [Abstract][Full Text] [Related]
20. The Salivary Microbiome in Polycystic Ovary Syndrome (PCOS) and Its Association with Disease-Related Parameters: A Pilot Study.
Lindheim L; Bashir M; Münzker J; Trummer C; Zachhuber V; Pieber TR; Gorkiewicz G; Obermayer-Pietsch B
Front Microbiol; 2016; 7():1270. PubMed ID: 27610099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
